Clear Cell RCC Leads Kidney Cancer Cases in South India: Apollo Study
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2026-04-15 03:30 GMT | Update On 2026-04-15 07:21 GMT
India: A recent study published in Apollo Medicine has shed light on the demographic patterns and histomorphological characteristics of renal cell carcinoma (RCC) in a South Indian population, highlighting trends that largely mirror global observations while underscoring important regional insights.
Conducted by Githa Rachel Oommen from the Department of Hematology and Clinical Pathology, Apollo Hospitals, Chennai, and Suganthi Krishnamurthy, the study provides valuable real-world data from a quaternary care setting, addressing the relative scarcity of Indian evidence in this domain.
The following were the key findings:
- A total of 116 renal cell carcinoma cases were analysed. The median age at diagnosis was 53 years.
- There was a clear male predominance, with over 70% of cases occurring in men.
- Clear cell RCC was the most common histological subtype, accounting for 83.6% of cases.
- Papillary RCC was the second most frequent subtype.
- A large proportion of tumours measured 4–7 cm in size, corresponding to stage pT1b.
- Most tumours were confined to the kidney at the time of diagnosis.
- The upper pole of the kidney was the most commonly involved site.
- Lymphovascular invasion, a marker of aggressive disease, was observed in 13.8% of cases.
- Regional lymph node involvement was present in a small proportion (3.4%) of patients.
- Partial nephrectomy was performed in 34 cases.
- These cases generally had a smaller mean tumour size.
- Only a small proportion of cases presented at an advanced pathological stage.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.